Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008

Gynecology

Free Subscription Articles published in Ann Oncol Retrieve available abstracts of 63 articles: HTML format

Single Articles

June 2008
1. AZIM HA JR , Peccatori FA, Scarfone G, Acaia B, et al
   Anthracyclines for gestational breast cancer: course and outcome of pregnancy.
   Ann Oncol. 2008;.
   PubMed     Related articles   
   
   
   
2. HICKEY M , Saunders C, Partridge A, Santoro N, et al
   Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer.
   Ann Oncol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   May 2008
3. WANG J , Short D, Sebire NJ, Lindsay I, et al
   Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE).
   Ann Oncol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. BAEKELANDT MM , Castiglione M
   Endometrial carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
   Ann Oncol. 2008;19 Suppl 2:ii19-20.
   PubMed     Related articles   
   
   
   
5. HAIE-MEDER C , Morice P, Castiglione M
   Cervical cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
   Ann Oncol. 2008;19 Suppl 2:ii17-8.
   PubMed     Related articles   
   
   
   
6. AEBI S , Castiglione M
   Epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
   Ann Oncol. 2008;19 Suppl 2:ii14-6.
   PubMed     Related articles   
   
   
   
7. PENTHEROUDAKIS G , Pavlidis N, Castiglione M
   Cancer, fertility and pregnancy: ESMO clinical recommendations for diagnosis, treatment and follow-up.
   Ann Oncol. 2008;19 Suppl 2:ii108-9.
   PubMed     Related articles   
   
   
   
8. CASALI PG , Jost L, Sleijfer S, Verweij J, et al
   Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up.
   Ann Oncol. 2008;19 Suppl 2:ii89-93.
   PubMed     Related articles   
   
   
   April 2008
9. ZHONG Q , Wen YJ, Yang HS, Luo H, et al
   Efficient inhibition of cisplatin-resistant human ovarian cancer growth and prolonged survival by gene transferred vesicular stomatitis virus matrix protein in nude mice.
   Ann Oncol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. DE LA MOTTE ROUGE T , Pautier P, Duvillard P, Rey A, et al
    Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor.
    Ann Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
11. BOSETTI C , Bertuccio P, Levi F, Lucchini F, et al
    Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis.
    Ann Oncol. 2008;19:631-40.
    PubMed     Related articles    Abstract available
    
    
    
12. RAPP K , Klenk J, Ulmer H, Concin H, et al
    Weight change and cancer risk in a cohort of more than 65,000 adults in Austria.
    Ann Oncol. 2008;19:641-8.
    PubMed     Related articles    Abstract available
    
    
    
13. FULCINITI F , Losito S, Botti G, Di Mattia D, et al
    Metastases to the breast: role of fine needle cytology samples. Our experience with nine cases in 2 years.
    Ann Oncol. 2008;19:682-7.
    PubMed     Related articles    Abstract available
    
    
    March 2008
14. MANGILI G , Montoli S, De Marzi P, Sassi I, et al
    The role of DNA ploidy in postoperative management of stage I endometrial cancer.
    Ann Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
15. SUZUKI S , Kajiyama H, Shibata K, Ino K, et al
    Is there any association between retroperitoneal lymphadenectomy and survival benefit in ovarian clear cell carcinoma patients?
    Ann Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
16. PSYRRI A , Kountourakis P, Scorilas A, Markakis S, et al
    Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression.
    Ann Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    February 2008
17. BARRETT SV , Paul J, Hay A, Vasey PA, et al
    Does body mass index affect progression-free or overall survival in patients with ovarian cancer? Results from SCOTROC I trial.
    Ann Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    January 2008
18. THASNI KA , Rakesh S, Rojini G, Ratheeshkumar T, et al
    Estrogen-dependent cell signaling and apoptosis in BRCA1-blocked BG1 ovarian cancer cells in response to plumbagin and other chemotherapeutic agents.
    Ann Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    December 2007
19. WITZEL ID , Muller V, Harps E, Janicke F, et al
    Trastuzumab in pregnancy associated with poor fetal outcome.
    Ann Oncol. 2007;.
    PubMed     Related articles   
    
    
    
20. NAWA A , Suzuki K, Kato S, Fujiwara S, et al
    Carbon beam therapy in recurrent ovarian cancer.
    Ann Oncol. 2007;.
    PubMed     Related articles   
    
    
    
21. PRAT A , Parera M, Peralta S, Perez-Benavente MA, et al
    Nadir CA-125 concentration in the normal range as an independent prognostic factor for optimally treated advanced epithelial ovarian cancer.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    November 2007
22. SWART AM , Burdett S, Ledermann J, Mook P, et al
    Why i.p. therapy cannot yet be considered as a standard of care for the first-line treatment of ovarian cancer: a systematic review.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
23. MARCHINI S , Marabese M, Marrazzo E, Mariani P, et al
    {Delta}Np63 expression is associated with poor survival in ovarian cancer.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
24. OYEN WJ , Bodei L, Giammarile F, Maecke HR, et al
    Targeted therapy in nuclear medicine--current status and future prospects.
    Ann Oncol. 2007;18:1782-92.
    PubMed     Related articles    Abstract available
    
    
    October 2007
25. LEE JM , Lee KB, Nam JH, Ryu SY, et al
    Prognostic factors in FIGO stage IB IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
26. SHIBATA K , Kajiyama H, Ino K, Terauchi M, et al
    Twist expression in patients with cervical cancer is associated with poor disease outcome.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
27. MIR O , Berveiller P, Ropert S, Goffinet F, et al
    Emerging therapeutic options for breast cancer chemotherapy during pregnancy.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
28. BRESSER PJ , Van Gool AR, Seynaeve C, Duivenvoorden HJ, et al
    Who is prone to high levels of distress after prophylactic mastectomy and/or salpingo-ovariectomy?
    Ann Oncol. 2007;18:1641-5.
    PubMed     Related articles    Abstract available
    
    
    
29. KONG A , Simera I, Collingwood M, Williams C, et al
    Adjuvant radiotherapy for stage I endometrial cancer: systematic review and meta-analysis.
    Ann Oncol. 2007;18:1595-604.
    PubMed     Related articles    Abstract available
    
    
    September 2007
30. LUCENTEFORTE E , Talamini R, Montella M, Dal Maso L, et al
    Macronutrients, fatty acids and cholesterol intake and endometrial cancer.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
31. LIN A , Yan WH, Xu HH, Gan MF, et al
    HLA-G expression in human ovarian carcinoma counteracts NK cell function.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
32. CORRAO G , Zambon A, Conti V, Nicotra F, et al
    Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
33. COUTANT C , Barranger E, Cortez A, Dabit D, et al
    Frequency and prognostic significance of HPV DNA in sentinel lymph nodes of patients with cervical cancer.
    Ann Oncol. 2007;18:1513-7.
    PubMed     Related articles    Abstract available
    
    
    
34. JAHAN I , Fujimoto J, Alam SM, Sato E, et al
    Role of protease activated receptor-2 in tumor advancement of ovarian cancers.
    Ann Oncol. 2007;18:1506-12.
    PubMed     Related articles    Abstract available
    
    
    August 2007
35. PAUTIER P , Ribrag V, Duvillard P, Rey A, et al
    Results of a prospective dose-intensive regimen in 27 patients with small cell carcinoma of the ovary of the hypercalcemic type.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
36. DELPECH Y , Cortez A, Coutant C, Callard P, et al
    The sentinel node concept in endometrial cancer: histopathologic validation by serial section and immunohistochemistry.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
37. PISANO C , Vesci L, Fodera R, Ferrara F, et al
    Antitumor activity of the combination of synthetic retinoid ST1926 and cisplatin in ovarian carcinoma models.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
38. RUGO H
    The breast cancer continuum in hormone-receptor positive breast cancer in postmenopausal women: evolving management options focusing on aromatase inhibitors.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
39. ARBYN M , Autier P, Ferlay J
    Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004.
    Ann Oncol. 2007;18:1423-5.
    PubMed     Related articles   
    
    
    July 2007
40. LARKIN JM , Kaye SB
    Potential clinical applications of epothilones: a review of phase II studies.
    Ann Oncol. 2007;18 Suppl 5:v28-34.
    PubMed     Related articles    Abstract available
    
    
    
41. DEVI BC , Tang TS, Corbex M
    Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia.
    Ann Oncol. 2007;18:1172-6.
    PubMed     Related articles    Abstract available
    
    
    
42. LORUSSO D , Di Stefano A, Carone V, Fagotti A, et al
    Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot' syndrome).
    Ann Oncol. 2007;18:1159-64.
    PubMed     Related articles    Abstract available
    
    
    June 2007
43. RUSSO A , Calo V, Augello C, Bruno L, et al
    4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily).
    Ann Oncol. 2007;18 Suppl 6:vi99-102.
    PubMed     Related articles    Abstract available
    
    
    
44. VESCHI S , Aceto G, Scioletti AP, Gatta V, et al
    High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability.
    Ann Oncol. 2007;18 Suppl 6:vi86-92.
    PubMed     Related articles    Abstract available
    
    
    May 2007
45. BIJELIC L , Jonson A, Sugarbaker P
    Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
46. WANG Y , Kristensen G, Borresen-Dale AL, Helland A, et al
    TP53 mutations and codon 72 genotype--impact on survival among ovarian cancer patients.
    Ann Oncol. 2007;18:964-6.
    PubMed     Related articles   
    
    
    
47. RIEDINGER JM , Bonnetain F, Basuyau JP, Eche N, et al
    Change in CA 125 levels after the first cycle of induction chemotherapy is an independent predictor of epithelial ovarian tumour outcome.
    Ann Oncol. 2007;18:881-5.
    PubMed     Related articles    Abstract available
    
    
    
48. AYANTUNDE AA , Parsons SL
    Pattern and prognostic factors in patients with malignant ascites: a retrospective study.
    Ann Oncol. 2007;18:945-9.
    PubMed     Related articles    Abstract available
    
    
    
49. 
    Epithelial ovarian carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up.
    Ann Oncol. 2007;18 Suppl 2:ii12-ii14.
    PubMed     Related articles       Free Full Text
    
    
    April 2007
50. FERRANDINA G , Ludovisi M, De Vincenzo R, Salutari V, et al
    Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    March 2007
51. ARBYN M , Raifu A, Autier P, Ferlay J, et al
    Burden of cervical cancer in Europe: estimates for 2004.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    February 2007
52. BELLATI F , Pernice M, Manci N, Palaia I, et al
    Hemoglobin variation and blood transfusion rates in patients affected by locally advanced cervical cancer undergoing neo-adjuvant chemotherapy followed by radical surgery: the role of erythropoietic growth factors.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
53. ANDREOPOULOU E , Gaiotti D, Kim E, Downey A, et al
    Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil(R)): Experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancer.
    Ann Oncol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    September 2006
54. ROSE PG
    Concurrent chemoradiation for locally advanced carcinoma of the cervix: where are we in 2006?
    Ann Oncol. 2006;17 Suppl 10:x224-9.
    PubMed     Related articles   
    
    
    June 2006
55. PIGNATA S , Pisano C, Di Maio M, Iodice F, et al
    Medical treatment of resistant or recurrent epithelial ovarian cancer.
    Ann Oncol. 2006;17 Suppl 7:vii49-vii50.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
56. LEGGE F , Ferrandina G, Scambia G
    From bio-molecular and technology innovations to clinical practice: focus on ovarian cancer.
    Ann Oncol. 2006;17 Suppl 7:vii46-vii48.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
57. CAPALBO C , Ricevuto E, Vestri A, Ristori E, et al
    BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models.
    Ann Oncol. 2006;17 Suppl 7:vii34-vii40.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    May 2006
58. SCARFONE G , Bolis G
    Multimodal approach to ovarian cancer.
    Ann Oncol. 2006;17 Suppl 5:v199-v200.
    PubMed     Related articles       Free Full Text
    
    
    
59. GALLIGIONI E , Arcuri C, Sorio R, Griso C, et al
    Gemcitabine and anthracyclines in platinum-resistant ovarian cancer.
    Ann Oncol. 2006;17 Suppl 5:v195-v198.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
60. LORUSSO D , Di Stefano A, Fanfani F, Scambia G, et al
    Role of gemcitabine in ovarian cancer treatment.
    Ann Oncol. 2006;17 Suppl 5:v188-v194.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
61. OZOLS RF
    Challenges for chemotherapy in ovarian cancer.
    Ann Oncol. 2006;17 Suppl 5:v181-v187.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    February 2006
62. HOTTE SJ , Oza A, Winquist EW, Moore M, et al
    Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study.
    Ann Oncol. 2006;17:334-40.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
63. VERGOTE I , Abram P
    Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents.
    Ann Oncol. 2006;17:200-4.
    PubMed     Related articles    Abstract available   Free Full Text
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: